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Abstract
Perinatal mental illness refers to psychiatric disorders that exist during pregnancy and up to 1 year after childbirth.
The aim of this systematic review was to discuss the use of Information and Communication Technologies (ICTs)
on perinatal depression (PeD) screening in the past three decades. Published articles were searched between 1990
and 2018, both in English and Spanish. In the search, we used different keywords, such as ‘‘pregnancy,’’ ‘‘de-
pression,’’ or ‘‘technology’’ in ScienceDirect, PubMed-NCBI, and Web of Science. We found 10 articles that
combined the use of ICTs and a focus on PeD screening. Studied periods included pregnancy (n=2) and post-
partum (n= 8). The telephone was the most commonly used communication method (n= 5), followed by the
Internet (n= 4). One investigation used both, the telephone and the Internet. The Edinburgh Postnatal Depression
Scale was the most frequently used screening measure (n= 8). The proportion of depressed perinatal women varied
across studies depending on the pregnancy status and the cutoff values used, showing a very broad range between
5.8 and 51.9 percent. Despite the increasing popularity of ICTs in health settings, their use in perinatal mental
health screening is still rare. Overall, encouraging findings have been reported when using ICTs for screening of
PeD, such as eliminating the need to travel to the health center to conduct the screening and allowing for a wider
dissemination. However, more research is needed to support their inclusion in perinatal care.
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Introduction
Perinatal mental illness refers to ‘‘psychiatric dis-orders that are prevalent during pregnancy and as long as
1 year after delivery.’’1 Although a number of mental dis-
orders have been reported during pregnancy and postpartum,
depression and anxiety are the most prevalent problems
worldwide.2 This review will focus on depression, which has
received most attention in perinatal research.
Perinatal depression (PeD) is estimated to affect between
3 and 6 percent of women.3 During pregnancy, depression
prevalence in different studies and countries has ranged from
6 to 12 percent.4,5 In the postpartum, depression has been
estimated to affect between 7 and 25 percent of women.6–10
PeD is a major public health concern because of its nega-
tive consequences for the mother, the fetus, and the baby.11 For
instance, depression during pregnancy has been linked to in-
creased childbirth complications, including premature birth, low
birth weight, and preeclampsia. Moreover, postpartum depres-
sion (during the first year after delivery) is associated with poor
performance in the babies’ behavioral, cognitive, and emotional
domains.12–14 Not surprisingly, identification and management
of PeD and other mental health disorders have become a fun-
damental goal of the World Health Organization.15
Fortunately, the perinatal period provides a unique op-
portunity for the detection of depressive symptoms because
of the continuous medical monitoring of women, especially
during pregnancy. Also encouragingly, previous studies and
guidelines have shown that assessment of PeD can be carried
out quickly with only one or two brief screening questions,
which might be as valid and effective as long, structured
mental health assessment methods.16–20
In this scenario, an early detection of depressive symp-
toms in the perinatal period, which reduces the impact of
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mental illness on the mother, the baby, and the family,21
should be feasible. Unfortunately, despite the benefits of
early detection and intervention of pregnant women with
depressive symptoms are well known and although we have
instruments to measure them, PeD is often undetected and,
consequently, undertreated or addressed after its onset.22,23
There might be several reasons to explain why the iden-
tification of PeD is still unsuccessful, including difficulties in
the health care professional and the mothers. On the one
hand, some factors explaining why prompt and adequate
screening by health care professionals is rare might include a
reduced awareness about the problem, time constraints for
exhaustive assessments during and between consultations,
lack of established policies for care, or unclear referral net-
works.4,24–27
On the other hand, barriers in perinatal women have also
been reported. For instance, some maternal and pregnancy
characteristics, such as being a young mother with an in-
termediate education level, being born abroad, and being in
the first trimester of pregnancy are related to lower consul-
tation of a mental health specialist.22 Other barriers in the
mother are related to sociocultural and environmental fac-
tors. Some of these include difficulties in combining
child care and face-to-face psychological interventions, not
knowing where to go to receive treatment, time limitations,
transportation difficulties, social stigma associated with
mental illness, and fear that their baby could be removed
from their care.28–32
In the light of the previous findings, the goal of this study
was to review how Information and Communication Tech-
nologies (ICTs) have been used in PeD screening and to
discuss to which extent they might help overcome some of
the barriers presented previously. During the past years, the
use of ICTs in the health service industry (eHealth) has in-
creased spectacularly, arguably because of the decrease in
their cost and their increased availability in the general pop-
ulation.33 For instance, in 2017 Internet access and portable
electronic devices connected to the Internet (e.g., smart-
phones, laptops, and tablets) were available to 87 and 65
percent of Europeans, respectively.34,35 Also importantly, 51
percent of individuals used the Internet to seek health-related
information in 2017.36
The use of ICTs in PeD might minimize some of the
aforementioned barriers experimented by perinatal women
when looking for mental health advice. For instance, ICTs
allow a flexible access to screening and treatment, which can
be performed anytime and anywhere, eliminating travel
costs and facilitating the combination of child care and self
care.37–39 In addition, ICTs offer anonymous help, which can
minimize stigmatization,40 improve help-seeking behaviors
among perinatal women,41 and decrease participants’ incli-
nation to give a socially desirable response, thus encouraging
more honest answers because of a sense of privacy and lack
of perceived judgment.42 In fact, anonymity seems to be a
key aspect in the assessment of PeD, as higher prevalence
rates of PeD have been obtained when women filled out a
questionnaire at home on their own compared with phone
calls by nurses.43
ICTs could also be useful for health professionals to
communicate with patients and colleges in a more effective
and immediate manner, as well as to support their decisions
or to seek information.44 Moreover, ICTs could make con-
sultations more efficient if screenings completed by the
mothers at their homes remotely informed the clinicians of
important undesired events, such as an increase in depressive
symptoms, without the need to have on-site consultations for
such assessments.45 In fact, health care professionals believe
that the use of ICTs in PeD screening has important benefits,
such as eliminating language barriers reducing redundancy
and human errors, and increasing the client’s privacy.46
This study will review the contributions of ICTs in the
field of PeD screening in the past three decades (since 1990).
In doing so, we will report the sample characteristics (e.g.,
pregnancy period), type of ICT employed (e.g., phone calls
or the Internet), procedures and instruments used for
screening, and the main findings in the perinatal literature. In
addition to providing an overview of existent research using
ICTs for PeD screening, the implications of the findings and
future lines of research will be discussed.
Methods
Scientific articles including the use of ICTs for depression
screening during the perinatal period were consulted after an
extensive literature search using vertical search options.
Literature search
The systematic search for scientific articles was carried
out in March 2018. The information was consulted on the
following databases: ScienceDirect, PubMed-NCBI, and
Web of Science. Key terms used are in line with previous
reviews on ICTs and health47,48 and included: ‘‘perinatal,’’
‘‘pregnant,’’ ‘‘pregnancy,’’ ‘‘prenatal,’’ ‘‘postnatal,’’ ‘‘post-
partum,’’ ‘‘depression,’’ ‘‘depressive symptoms,’’ ‘‘technol-
ogy,’’ ‘‘technologies,’’ ‘‘Internet,’’ ‘‘eHealth,’’ ‘‘mHealth,’’
‘‘ICT,’’ ‘‘mobile,’’ ‘‘app,’’ ‘‘application,’’ ‘‘phone,’’ ‘‘tele-
phone,’’ ‘‘smartphone,’’ ‘‘tablet,’’ ‘‘PDA,’’ and ‘‘screening.’’
The search was limited to articles published between 1990
and March 2018. Key terms were searched in the abstract.
The specific search terms used in ScienceDirect are re-
ported in Appendix 1. We used the same search strategy for
all databases.
Two of the authors, namely V.M.B. and C.S.R, conducted
the research independently and selected the articles (see a
more detailed description in section ‘‘Literature selection’’).
The results obtained by each researcher were compared to
ensure that the final database included all the articles. The
agreement in the number of articles found between both re-
searchers was 89 percent.
Literature selection
A prerequisite to select a study was that any form of ICT
was used in the screening of PeD. The review includes ar-
ticles published in English and Spanish to provide an over-
view of the use of ICTs for PeD screening in the past decades
and to discuss its current state of the art. The eligibility of
studies was assessed following a series of steps according to
eligibility criteria (Table 1). First, a selection was made by
looking at the article title and abstract. Then, the full text was
read for the selected articles and additional references were
searched within the text. A flow diagram of the selec-
tion process is given in Figure 1. The diagram will only
be presented for one researcher (V.M.B.) to facilitate the
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readability of the text. As described previously, the same
procedure was followed by C.S.R.
Results
Sample characteristics
After comparing the findings from both researchers, the
first search yielded 188 results. Of these, 10 articles met the
inclusion criteria (Table 2).
Sample characteristics are given in Table 2. The majority
of studies (n= 8) have been conducted in the United
States.28,39,41,43,49–52 The remaining two investigations were
from England53 and Canada.54 Most studies have included
women older than 18 years of age, but four articles also
recruited adolescent mothers.43,51,52,54
Regarding the period of interest, most investigations fo-
cused on postpartum (n = 8, 80 percent).28,41,43,49–52,54 Only
two articles (20 percent) screened for depression during the
prenatal period.39,53 Also interestingly, we observed that the
moment in which screening was conducted varied widely
Table 1. Inclusion and Exclusion Criteria
Inclusion Exclusion
Articles Full text not being an article,
Reviews, Protocols
English or Spanish Full text no available in
English or Spanish
Focused on human Animal studies
Using ICT for screening Including face to face session
Focused on screening Result no showing proportion
of depressed women
Focused on depression Evaluation not including
depression measure
Perinatal women Studies focused on general
population, no pregnant
women, with a focus on
fathers or babies and
perinatal women after
12 months postpartum
ICT, Information and Communication Technologies.
FIG. 1. Flow diagram of study selection. ICT, Information and Communication Technology.
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across investigations. For instance, in the prenatal period,
studies included women at any gestational stage.39,53 Simi-
larly, the period of interest during the postpartum varied
from 7 days after childbirth to 6 months postpartum de-
pending on the study (n= 7; 70 percent),28,41,43,49,51,52,54
whereas one investigation included screening up to 1 year
after delivery.50
Type of ICT
As given in Table 2, ICTs have included the phone (n = 5,
50 percent)39,41,49,51,54 and the Internet (n= 4, 40 per-
cent).28,50,52,53 One investigation used both types of ICTs.43
For those using the telephone, screening was carried out
through telephone calls (n = 4, 40 percent)41,43,51,54 or
through an interactive voice response system (n = 2, 20 per-
cent).39,49 By contrast, studies that preferred the Internet as a
way of screening for PeD, have used web pages (n = 3, 30
percent),28,50,52 a tablet application (n = 1, 10 percent),53 or
e-mails (n = 1, 10 percent).43
Instruments used to assess
depressive symptomatology
The Edinburgh Postnatal Depression Scale (EPDS)55 has
been the most frequently selected tool for depression
screening across studies (n = 8, 80 percent).28,39,41,43,49,52–54
Some authors used the Postpartum Depression Screening
Scale (PDSS)56 as an alternative to the EPDS (n = 2, 20 per-
cent),50,51 whereas others administered the Whooley ques-
tionnaire20 or the DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition) Structured
Clinical Interview for Axis I Disorders—Clinician Version
(SCID-CV)57 as a complement to the EPDS (n = 2, 20 per-
cent).53,54
Although screening tools were similar in the majority of
studies, the selected cutoff points were very diverse. The
screening cutoff for the EPDS ranged from 8 to 13 across
investigations. For instance, three studies (30 percent) used a
single cutoff score of 8,41 10,43 or 13,52 whereas other au-
thors (n= 5, 50 percent)28,39,49,53,54 established two cutoff
points, one for moderate (EPDS q10–11) and another for
severe (EPDS q12–13) depressive symptoms. Taking the
PDSS, selected cutoffs for moderate and severe depression
were 60–80 and >80, respectively.50,51
Study findings
When screening occurred during pregnancy, the propor-
tion of women with depressive symptoms varied consider-
ably across studies. Some authors39 reported that 9.3 percent
women presented with mild depressive symptoms (EPDS
>10p 11), whereas 29.6 percent were categorized as expe-
riencing major depressive symptoms (EPDS q12). A most
recent study revealed a lower proportion of severely de-
pressed women, that is, a 7.2 percent of women with EPDS
scores of between 10 and 12 and only 5.8 percent of women
indicating EPDS scores >13.53
The proportion of depressed women in the postnatal pe-
riod was somewhat higher than those reported during preg-
nancy. However, results varied greatly across investigations,
arguably as a result of the different cutoffs used. Not sur-
prisingly, the more restrictive the cutoff was, the fewer de-
pressed women were reported. For instance, one study using
an EPDS cutoff of 8 obtained that 51.9 percent of partici-
pants were depressed.41 By contrast, when the EPDS cutoff
was set to q10, the proportion of depressed women de-
creased to between 6.254 and 17 percent.49 The most re-
commended cutoff of 12 yielded a proportion of depressed
women of between 3.454 and 11.1 percent.49 Finally, when
using the most restrictive cutoff of EPDS >13, the proportion
of women depressed ranged from 5.528 to 16 percent.52
During the postpartum, depression screening using the
PDSS with a cutoff of 80 indicated that between 951 and 23
percent 50 of women met criteria for major postpartum de-
pression. When authors used a lower cutoff (between 60
and 80), the prevalence of depression was found to be
15 percent.51
Discussion
This study aimed at reviewing the existing literature into
the use of ICT for PeD. The importance of the topic lies in
the fact that use of these tools, which has boosted in health
settings in the past decades because of their increased
availability in the population,33 has been argued to overcome
some of the existent barriers in screening for PeD.40–42 For
instance, health care professionals have reported time con-
straints that make active, repeated assessment unfeasible.44
In addition, perinatal women have indicated that anonymity
and flexibility in the time to perform the assessment or to
receive treatment are important factors influencing their
decision to search for mental health assistance.58,59
Despite the potential of ICT in PeD screening, this review
evidenced that the integration of ICT in this field is still very
rare. In addition, our study revealed some strengths (e.g., the
consensus about the screening tool to be used) and weak-
nesses (e.g., inconsistency in the cutoffs used, infrequent use
of apps for telemonitoring, exclusion of teenage mothers, and
a major focus on the postpartum period) of the existent
literature.
One important finding in this study was that the EPDS seems
to be the preferred tool in studies using ICT for PeD screen-
ing,28,39,41,43,49,52–54 followed by the PDSS.50,51 Readers should
keep in mind that the EPDS and the PDSS are not diagnostic
tools, so women scoring above the cutoff should undergo a
formal diagnosis assessment by a mental health specialist.56,60,61
However, investigations have shown that brief screening ques-
tions have a good diagnostic validity compared with structured
mental health assessment and are recommended before a more
in-depth evaluation is made.16–20
In contrast to the popularity of the EPDS, our review re-
vealed that the ICT use to perform the final diagnostic as-
sessment has been very rare,54 which suggests that health
care professionals still rely on face-to-face interaction for
the diagnosis of PeD. A recent study supports this idea, as
sanitarians (psychologists and psychiatrists) seem to trust
e-mental health applications for screening, prevention, fol-
lowup, and positive psychology intervention, but they are
skeptical with regard to their use in other forms of treatment
and diagnosis of maternal depression.45
Another interesting result in this investigation was that,
despite the consensus about the use of the EPDS for PeD
screening using ICT, the cutoff to be used is not well-
established. Specifically, a number of studies selected the
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recommended cutoff of 12 for severe depressive symp-
toms,28,39,49,53,54 but less (EPDS >8 or EPDSq10)41,43 and
more restrictive cutoffs have also been utilized (EPDS
q13).52 This is problematic, as prevalence scores will likely
differ as a function of the cutoff used and, most importantly,
this will affect the recommendation made to the mothers.
According to the existent literature on the EPDS, the re-
commended cutoff of 1255 should be preferred unless clearly
justified. In support of this, studies using this cutoff have
reported prevalence scores between 3.4 and 11.1 percent,
which are similar to the prevalence reported by the American
Psychiatric Association.3
An important goal in this study was to explore the types of
ICT used by researchers. The past decades have seen a surge in
the number tools available, from the first fixed devices (e.g.,
phones and computers) to smartphones and wearable technol-
ogy that have made ecological, momentary assessment feasi-
ble. Despite the current advances in ICT, research into PeD has
mostly relied on phone calls and, to a lesser extent, web pages
for screening.28,41,43,50–52,54 In fact, our search indicated that
only one study used an application for a portable device, that is,
a tablet53 and no investigation included a smartphone app to
ecologically screen for depression.
At this point, some considerations should be made. Recent
reports have repeatedly indicated that the proportion of in-
dividuals owning a portable electronic device connected to
the Internet35 and the use of the Internet to seek for health-
related information36 have grown spectacularly. Similarly,
the use of smartphone applications by perinatal women is
becoming more and more frequent.62 In fact, the use of
smartphone apps is argued to be the current gold standard
assessment method in health settings as it reduces costs
(phone calls by the health care professional are substituted
for a continuous assessment with the app), it allows for tel-
emonitoring (it captures and communicates data in real
time), it is ecological (mothers can answer wherever they are
removing the need to connect to their computer at home or to
travel to the clinic), and it is minimally invasive (mothers can
decide when to answer to the app, which is more difficult
when phone calls are used for assessment).63 Also impor-
tantly, there is recent evidence to suggest that the use mobile
devices when administering validated screening scales does
not affect data equivalence compared with traditional as-
sessment modes, such as paper64,65 and that less personal
assessment tools (e.g., mail as opposed to phone calls) re-
sult in higher PeD prevalence rates,43 supporting the use of
more impersonal screening tools, such as smartphone apps,
in PeD.
In addition to the infrequent use of modern, anonymous
ICT screening tools, our review of the literature also evi-
denced a tendency to exclude teenage mothers in studies
using ICT for PeD screening. This is alarming because young
mothers are less likely to consult a mental health specialist.22
Furthermore, teenager mothers seem to present with higher
depression prevalence rates than adult mothers (17 and 3.3
percent, respectively) and many of them (up to 20 percent)
report having committed suicide attempts during pregnan-
cy.66 For these reasons and also because this population ar-
guably has a high knowledge of ICTs, teenage mothers are
good candidates to benefit from ICT screening programs for
PeD and should not be excluded from future research into
this topic.
A final shortcoming revealed by the present investigation
is that the majority of reviewed studies had a focus on the
postnatal period, despite the well-established benefits of
early screening during pregnancy.37–39 Considering the ex-
isting link between prenatal and postpartum depression,67–69
the high prevalence rates of prenatal depression obtained in
this review (between 5.8 and 29.6 percent), and the conse-
quences of prenatal depression on the fetus and later on
the baby,12–14 routine depression screening throughout the
pregnancy period should be an urge.
Related to this, we found that the majority of reviewed
investigations have been cross-sectional studies with a single
screening point, with no consensus about the best time for
screening during pregnancy or postpartum and with no fol-
lowup. In our opinion, the fact that prenatal depressive
symptoms often persist at least during the first year post-
partum,70–72 future research and screening programs should
be characterized by a more frequent assessment starting early
during pregnancy and finishing no sooner than 1 year after
delivery. We believe that the use of ICTs will surely facili-
tate this repeated screening of depressive symptoms during
obstetric (pregnancy) and pediatric (postpartum) revisions.41
However, further research is needed to determine the optimal
quantity and timing of evaluations to rapidly and efficiently
detect the onset of PeD.
Implications for Future Research
and Clinical Practice
The use of e-health and m-health will surely change the
way screening will happen in the future in perinatal care.
There are, however, some challenges to their implementation
that will need to be addressed in future developments.
Engagement, for instance, is a critical element that will de-
termine whether individuals are willing to use these tech-
nologies. There are some characteristics intrinsic to ICTs that
may favor engagement in perinatal women. For instance,
ICTs give the control and responsibility of medical care to
the patient, who can decide when and how to perform the
evaluation.
Making the technology customizable is another way of
enhancing engagement, as reported by women.38,58 Virtual
and augmented reality might serve this purpose,73,74 as both
technologies make customization feasible. To date, however,
the utility of virtual and augmented reality for mental health
screening in perinatal women remains unexplored. Other
strategies to promote engagement in self-monitoring using
ICT are gamification and social interactions.75,76 For in-
stance, participating women could be allowed to share their
experiences with other women using the same technologies
and could obtain rewards in the form of unlocking treatment
content (i.e., a module on emotion regulation or psychology
quotes) as they respond to the assessments.
As a final remark, we would like to draw attention to
perceived utility and ease of use as key factors that should be
considered in future developments of ICT in perinatal care,
as both elements are excellent predictors of technology
use.77 Some strategies in this direction would include in-
volving the target population in technology development and
providing immediate feedback to the individual and the
health care provider.78–80 To sum, what this study indicates
is that the use of ICT in perinatal screening is very limited
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and mostly represented by old-fashioned tools that make
repeated, self-monitoring and telemonitoring almost impos-
sible. There is a need to adopt more modern screening
strategies that eliminate common barriers for seeking mental
care in the perinatal period.
Conclusions
Routine screening for perinatal mental health is crucial
both for the mother and the baby.51 However, barriers in the
mother (e.g., difficulties travelling to the clinic, the stigma
of mental health, and combining childcare and face-to-face
consultations) and the health care professional (e.g., lack of
time) make repeated assessment difficult. The use of ICT,
especially smartphones, has been argued to overcome some
of the limitations described previously as it allows for tele-
monitoring without the need for face-to-face interactions and
eliminates the need to involve a human evaluator.81 Not
surprisingly, smartphone apps are perceived by many as the
current gold standard assessment tools in health settings.44–46,65
Despite the aforementioned potential advantages of using
smartphone apps for routine screening of depression in
perinatal women, our review underlined that (a) ICT meth-
ods used to date tend to require a human evaluator (e.g.,
phone calls), (b) repeated screening to explore the evolution
of mothers is very rare (frequently only once), (c) the cutoffs
used for depression have been inconsistent, (d) the focus has
been mostly on postpartum mental health, and (e) teenage
mothers have been frequently ignored. In the light of these
findings, we believe that there is an important gap in the
literature into screening for PeD using ICT. Future research
should explore the feasibility and utility of routine screening
from early pregnancy periods to at least 1 year postpartum
using smartphone apps, so that the onset of depression can be
rapidly detected at any stage during the perinatal period.
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Appendix 1. Final Search Terms in Science Direct
Search Keywords Results
1 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘technology’’ AND ‘‘screening’’ 0
2 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘technologies’’ AND ‘‘screening’’ 0
3 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘Internet’’ AND ‘‘screening’’ 4
4 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 1
5 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
6 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
7 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
8 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘app’’ AND ‘‘screening’’ 0
9 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘application’’ AND ‘‘screening’’ 0
10 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘phone’’ AND ‘‘screening’’ 2
11 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘telephone’’ AND ‘‘screening’’ 3
12 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
13 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘tablet’’ AND ‘‘screening’’ 1
14 ‘‘perinatal’’ AND ‘‘depression’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
15 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘technology’’ AND ‘‘screening’’ 0
16 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘technologies’’ AND ‘‘screening’’ 0
17 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘Internet’’ AND ‘‘screening’’ 3
18 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 1
19 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
20 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
21 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
22 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘app’’ AND ‘‘screening’’ 0
23 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘application’’ AND ‘‘screening’’ 1
24 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘phone’’ AND ‘‘screening’’ 0
25 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘telephone’’ AND ‘‘screening’’ 1
26 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
27 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘tablet’’ AND ‘‘screening’’ 0
28 ‘‘perinatal’’ AND ‘‘depressive symptoms’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
29 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘technology’’ AND ‘‘screening’’ 0
30 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘technologies’’ AND ‘‘screening’’ 0
31 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘Internet’’ AND ‘‘screening’’ 2
32 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
33 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
34 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
35 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
36 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘app’’ AND ‘‘screening’’ 0
37 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘application’’ AND ‘‘screening’’ 3
38 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘phone’’ AND ‘‘screening’’ 2
39 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘telephone’’ AND ‘‘screening’’ 2
40 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
41 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘tablet’’ AND ‘‘screening’’ 2
42 ‘‘pregnant’’ AND ‘‘depression’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
43 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘technology’’ AND ‘‘screening’’ 0
44 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘technologies’’ AND ‘‘screening’’ 0
45 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘Internet’’ AND ‘‘screening’’ 1
46 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
47 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
48 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
49 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
50 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘app’’ AND ‘‘screening’’ 0
51 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘application’’ AND ‘‘screening’’ 0
52 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘phone’’ AND ‘‘screening’’ 0
53 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘telephone’’ AND ‘‘screening’’ 0
54 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
55 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘tablet’’ AND ‘‘screening’’ 0
56 ‘‘pregnant’’ AND ‘‘depressive symptoms’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
57 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘technology’’ AND ‘‘screening’’ 1
58 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘technologies’’ AND ‘‘screening’’ 1
59 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘Internet’’ AND ‘‘screening’’ 2
60 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
61 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
62 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
(continued)
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Appendix 1. (Continued)
Search Keywords Results
63 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
64 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘app’’ AND ‘‘screening’’ 0
65 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘application’’ AND ‘‘screening’’ 5
66 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘phone’’ AND ‘‘screening’’ 3
67 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘telephone’’ AND ‘‘screening’’ 7
68 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
69 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘tablet’’ AND ‘‘screening’’ 0
70 ‘‘pregnancy’’ AND ‘‘depression’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
71 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘technology’’ AND ‘‘screening’’ 0
72 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘technologies’’ AND ‘‘screening’’ 0
73 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘Internet’’ AND ‘‘screening’’ 1
74 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
75 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
76 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
77 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
78 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘app’’ AND ‘‘screening’’ 0
79 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘application’’ AND ‘‘screening’’ 0
80 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘phone’’ AND ‘‘screening’’ 0
81 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘telephone’’ AND ‘‘screening’’ 2
82 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
83 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘tablet’’ AND ‘‘screening’’ 0
84 ‘‘pregnancy’’ AND ‘‘depressive symptoms’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
85 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘technology’’ AND ‘‘screening’’ 0
86 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘technologies’’ AND ‘‘screening’’ 0
87 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘Internet’’ AND ‘‘screening’’ 0
88 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
89 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
90 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
91 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
92 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘app’’ AND ‘‘screening’’ 0
93 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘application’’ AND ‘‘screening’’ 0
94 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘phone’’ AND ‘‘screening’’ 1
95 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘telephone’’ AND ‘‘screening’’ 0
96 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
97 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘tablet’’ AND ‘‘screening’’ 2
98 ‘‘prenatal’’ AND ‘‘depression’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
99 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘technology’’ AND ‘‘screening’’ 0
100 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘technologies’’ AND ‘‘screening’’ 0
101 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘Internet’’ AND ‘‘screening’’ 0
102 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
103 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
104 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
105 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
106 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘app’’ AND ‘‘screening’’ 0
107 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘application’’ AND ‘‘screening’’ 0
108 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘phone’’ AND ‘‘screening’’ 0
109 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘telephone’’ AND ‘‘screening’’ 0
110 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
111 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘tablet’’ AND ‘‘screening’’ 0
112 ‘‘prenatal’’ AND ‘‘depressive symptoms’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
113 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘technology’’ AND ‘‘screening’’ 1
114 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘technologies’’ AND ‘‘screening’’ 1
115 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘Internet’’ AND ‘‘screening’’ 2
116 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
117 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
118 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
119 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
120 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘app’’ AND ‘‘screening’’ 0
121 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘application’’ AND ‘‘screening’’ 2
122 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘phone’’ AND ‘‘screening’’ 3
123 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘telephone’’ AND ‘‘screening’’ 6
124 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
(continued)
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Appendix 1. (Continued)
Search Keywords Results
125 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘tablet’’ AND ‘‘screening’’ 1
126 ‘‘postnatal’’ AND ‘‘depression’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
127 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘technology’’ AND ‘‘screening’’ 1
128 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘technologies’’ AND ‘‘screening’’ 1
129 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘Internet’’ AND ‘‘screening’’ 1
130 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
131 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
132 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
133 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
134 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘app’’ AND ‘‘screening’’ 0
135 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘application’’ AND ‘‘screening’’ 0
136 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘phone’’ AND ‘‘screening’’ 0
137 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘telephone’’ AND ‘‘screening’’ 1
138 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
139 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘tablet’’ AND ‘‘screening’’ 1
140 ‘‘postnatal’’ AND ‘‘depressive symptoms’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
141 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘technology’’ AND ‘‘screening’’ 2
142 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘technologies’’ AND ‘‘screening’’ 2
143 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘Internet’’ AND ‘‘screening’’ 5
144 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
145 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
146 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
147 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
148 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘app’’ AND ‘‘screening’’ 0
149 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘application’’ AND ‘‘screening’’ 3
150 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘phone’’ AND ‘‘screening’’ 3
151 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘telephone’’ AND ‘‘screening’’ 13
152 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
153 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘tablet’’ AND ‘‘screening’’ 0
154 ‘‘postpartum’’ AND ‘‘depression’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
155 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘technology’’ AND ‘‘screening’’ 1
156 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘technologies’’ AND ‘‘screening’’ 1
157 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘Internet’’ AND ‘‘screening’’ 2
158 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘eHealth’’ AND ‘‘screening’’ 0
159 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘mHealth’’ AND ‘‘screening’’ 0
160 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘ICT’’ AND ‘‘screening’’ 0
161 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘mobile’’ AND ‘‘screening’’ 0
162 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘app’’ AND ‘‘screening’’ 0
163 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘application’’ AND ‘‘screening’’ 0
164 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘phone’’ AND ‘‘screening’’ 0
165 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘telephone’’ AND ‘‘screening’’ 2
166 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘smartphone’’ AND ‘‘screening’’ 0
167 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘tablet’’ AND ‘‘screening’’ 0
168 ‘‘postpartum’’ AND ‘‘depressive symptoms’’ AND ‘‘PDA’’ AND ‘‘screening’’ 0
109
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